Clinical Trial Detail

NCT ID NCT03815643
Title Avelumab Program Rollover Study
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications

Advanced Solid Tumor

Therapies

Avelumab

Age Groups: adult senior

No variant requirements are available.